| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 12.63 | 0.10 (+0.80%) | 6.92 - 14.33 | 59.7 thousand (Below Avg) |
Market data as of 4:01PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 12.50 |
|---|---|
| Previous Close | 12.53 |
| Day's Range | 12.44 - 12.63 |
| Market Cap | 379.3M |
| Avg Volume (10 Day) | 103.2K |
| Price/Earnings (Trailing 12 Mo.) | 5.7x |
| Earnings Per Share (Trailing 12 Mo.) | 2.19 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Cambrex To Present At Jefferies 2013 Global Healthcare Conference
PR Newswire - Thursday 05/23/2013 8:48 AM ET
Cambrex To Present At UBS Global Healthcare Conference
PR Newswire - Monday 05/13/2013 1:48 PM ET
Cambrex Reports First Quarter 2013 Financial Results
PR Newswire - Friday 05/03/2013 7:00 AM ET
Cambrex To Announce First Quarter 2013 Financial Results On May 3, 2013
PR Newswire - Tuesday 04/30/2013 8:10 AM ET
Cambrex To Present At The 12th Annual Needham Healthcare Conference
PR Newswire - Tuesday 04/23/2013 9:46 AM ET
| CBM | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 6.04% | |
| Net Income Growth (1yr) | 334.29% | |
| Total Debt/Equity | 0.43 | |
| LT Debt/Equity | 0.43 | |
| Earnings Yield | 17.54% | |
| Price/Sales | 1.34 |
| Company | Last | Change |
|---|---|---|
| 3SBio Inc | 16.59 | +0.06% |
| Osiris Therapeutics Inc | 11.02 | -0.45% |
| Insmed Inc | 12.93 | +3.94% |
| Cerus Corp | 5.16 | +0.78% |
| Enanta Pharmaceuticals Inc | 20.00 | +0.70% |
Data is delayed by at least 15 min.